相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Caroline R. Baumal et al.
OPHTHALMOLOGY (2020)
Safety of 5914 intravitreal ziv-aflibercept injections
Sumit Randhir Singh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective
Freekje van Asten et al.
PLOS ONE (2018)
Systemic Safety in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration: A Patient-Level Pooled Analysis
Marco A. Zarbin et al.
OPHTHALMOLOGY RETINA (2018)
Serious Adverse Events with Bevacizumab or Ranibizumab for Age-Related Macular Degeneration: Meta-analysis of Individual Patient Data
Maureen G. Maguire et al.
OPHTHALMOLOGY RETINA (2017)
Ten years of anti-vascular endothelial growth factor therapy
Napoleone Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis
Eric H. Souied et al.
OPHTHALMIC EPIDEMIOLOGY (2016)
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2016)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Michael Tolentino
SURVEY OF OPHTHALMOLOGY (2011)
分享论文
